Example collocations logo

Cervical in sentence

77 examples of Cervical in a sentence

For the first time, the number of deaths caused by cervical cancer every year is poised to outstrip the total caused by childbirth.
Over the same period, however, annual deaths from cervical cancer have increased by almost 40%, to 266,000.
Even as better standards of care continue to cut maternal mortality, cervical cancer deaths are expected to rise further.
Human papillomavirus (HPV) vaccines, coupled with screening and treatment, could prevent the vast majority of cervical cancer cases.
But almost 90% of the women who die from cervical cancer are in developing countries, where, for too many of them, screening services are unavailable, and treatment even less so.
As former Additional Secretary at the Ministry of Health and Family Welfare in India, the country with the largest number of cervical cancer deaths in the world, I have seen the impact of the disease with my own eyes.
Yet, with better treatments for HIV becoming available, women are now surviving HIV only to die from cervical cancer.
In 2010, the total global cost of cervical cancer was estimated to be around $2.7 billion per year.
Safe and effective HPV vaccines have been on the market since 2006, protecting against HPV types 16 and 18, which cause 70% of all cervical cancer cases.
Moreover, cervical cancer strikes women during their most economically productive years, when their contribution to society and the economy is greatest.
A study published by WHO and the London School of Hygiene and Tropical Medicine in June predicts that vaccinating 58 million girls in 179 countries would prevent 690,000 cases of cervical cancer and 420,000 deaths from the disease.
But we must keep the threat of cervical cancer firmly in our sights.
It is imperative to act now to ensure that every girl has access to HPV vaccines and a healthy future free from cervical cancer, no matter where she lives.
After just one year, Rwanda reported vaccinating more than 93% of its adolescent girls against the human papillomavirus (HPV) – by far the largest cause of cervical cancer.
Of the 275,000 women and girls who die of cervical cancer every year, 88% live in developing countries, where mortality rates can be more than 20 times higher than in France, Italy, and the United States.
If it turns out that girls at risk of not receiving all three doses of the HPV vaccine are also those with an elevated risk of being infected and missing cervical screenings as adults, they may be slipping through not one but two nets.
What we do know is that HPV is a highly infectious sexually transmitted virus, which is responsible for almost all forms of cervical cancer.
Whatever the reason, unless coverage for all three doses increases, cervical cancer and pre-cancer rates will increase.
They have seen the horrors of cervical cancer, with women in the prime of their lives presenting with late-stage disease and suffering slow and painful deaths.
Without changes in prevention and control, deaths from cervical cancer worldwide are projected to rise almost two-fold by 2030, to more than 430,000 per year.
Yet failure to reach the 80% coverage mark means that 50,000 American girls alive today will develop cervical cancer, as will another 4,400 girls with each year of delay.
Overcoming these challenges is essential to reducing cervical cancer and pre-cancer rates in the coming years.
Chest X-rays for lung cancer and Pap tests for cervical cancer have received similar, albeit less definitive, criticism.
Diseases that in high-income countries are preventable, like cervical cancer, or treatable, such as diabetes, are often death sentences in developing countries.
They include low-cost drugs to reduce heart attacks, vaccines to prevent cervical cancer, and the same tobacco taxes and advertising rules that dramatically cut smoking rates throughout Europe and the US.
Successes with screening and treatment of breast, colo-rectal, and cervical cancer have also helped.
In middle-income countries, prices would more closely reflect a country’s ability to pay (for example, GSK cut the price of its cervical cancer vaccine, Cervarix, by 60% in the Philippines and gained a 14-fold increase in volume sales).
Vaccinating girls against the human papillomavirus (HPV), and screening women on a routine basis, can drastically reduce deaths from cervical cancer.
When public health systems do not cover critical services – for example, cervical cancer screening – people are forced either to forego those services or to pay out of pocket for them.
But if countries are to succeed in protecting and empowering girls, they must also embrace the promise of a key initiative: to expand access to the vaccine for human papillomavirus, which causes the vast majority of cervical cancer cases.
Back